High hopes (but not dry) in Feinstein drug/booze center
By GREGORY ZELLER // To properly study the effects of booze, weed and other drugs on behavioral health and neurological impairment, the Feinstein Institutes for Medical Research would like to…
opioid crisis
No. 1019: In which toilets shine, tourism stays home and the Gettysburg Address speeds by (heads up, men!)
Break in the action: Welcome to Wednesday, dear readers, as the last action-packed workweek before the hectic holiday season rumbles to its manic midpoint. Yes, next week is Thanksgiving…
No. 1,018: On classic lit, ace Pasternack partnerships and adorable teddy bears – and wow, this guac is spicy!
End note: Welcome to Friday, intrepid innovators, and the exciting conclusion of both a chilly Long Island workweek and the longest federal-government shutdown in American history. Your well-earned weekend…
NY’s tide has turned, but only love can end opioid deaths
By JEFFREY L. REYNOLDS // Imagine getting a $3,200 return on every dollar you invested, while simultaneously saving 6,523 lives over the course of just two years. The New York…
No. 946: On sweet treats, Lincoln’s legacy and better healthcare managers … and have you been hurt at work?
Throwing a few changeups: Batter up, dear readers! It’s Wednesday out there, and another Long Island Winter workweek – snow, rain, cold, wind, the works – is rounding the…
Magic pill? No. But Journavx could provide opioid assist
By JEFFREY L. REYNOLDS // People in acute pain might be relieved to know that the U.S. Food and Drug Administration recently approved Journavx, a novel painkiller that aspires to…
No. 930: It’s a royal flush with Bernard King, the very first Burger King and the king of the neural bypass
Last leg: Welcome to Wednesday, dear readers, as the first week of December rocks on and the last month of 2024 (!) rolls toward its jingle-belling conclusion. The big…